Cell-based immunotherapy treatments, while promising, are often hindered by high costs associated with the collection, processing, and storage of immune cells. These costs can limit patient access to potentially life-saving therapies.

ImmuneCyte offers immune cell banking services designed to reduce the financial burden of cell-based immunotherapies. Utilizing its proprietary CAR-TXpress platform, ImmuneCyte provides cost-effective cryopreservation and storage solutions for a patient's or donor's immune cells. This allows for the preservation of immune cells at a point in time when they are healthy and functional, for potential use in future treatments. By lowering the costs associated with cell storage, ImmuneCyte aims to make these advanced therapies more accessible to a broader range of patients.

Proprietary CAR-TXpress platform for efficient and cost-effective cryopreservation

Long-term storage of immune cells, including T cells, NK cells, and other cell types

Quality control and cell viability testing to ensure high-quality cell preservation

Secure and compliant storage facilities with advanced monitoring systems

ImmuneCyte's primary customers include patients undergoing or considering cell-based immunotherapies, as well as researchers and pharmaceutical companies involved in cell therapy development.